Biogen Idec (BIIB), Eisai Enter Development Agreement for Two Alzheimer’s Disease Drugs
Tweet Send to a Friend
Biogen Idec, Inc. (Nasdaq: BIIB) and Eisai Co. announced that they have entered into a collaboration to develop and commercialize ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
